{"schema_version":"secwatch.filing_event.v1","accession":"0001012975-26-000195","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2026-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.643973+00:00","generated_at":"2026-05-16T01:23:58.318224+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oramed receives warrant to buy 100k Scilex shares at $20 in exchange for deferring amortization payment","bullets":["Oramed deferred its right to receive an amortization payment from Scilex due Oct 1, 2025; payment was made in Nov 2025.","Oramed received a warrant to purchase 100,000 shares of Scilex common stock at $20.00 per share, expiring Dec 13, 2029.","Warrant issued under Section 4(a)(2) and Rule 506(b); Scilex agreed to file resale registration statement.","Beneficial ownership limited to 4.99% (can be raised to 9.99% with 61 days' notice).","Warrant immediately exercisable; exercise price subject to anti-dilution adjustments with floor of $8.22."],"urls":{"canonical":"https://secwatch.observer/filing/0001012975-26-000195","json":"https://secwatch.observer/filing/0001012975-26-000195.json","markdown":"https://secwatch.observer/filing/0001012975-26-000195.md","text":"https://secwatch.observer/filing/0001012975-26-000195.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/0001012975-26-000195-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/ormp-20260219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:23:58.318224+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"438f742d6712e25373d98fe4221fdf789abee70a","claim":"ORAMED PHARMACEUTICALS INC. entered into Warrant Agreement with Scilex Holding Company (effective 2026-02-19).","evidence_excerpt":"On February 19, 2026, Oramed Pharmaceuticals Inc. (the “Company”) entered into a Warrant Agreement (the “Warrant Agreement”) with Scilex Holding Company (“Scilex”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/0001012975-26-000195-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Scilex Holding Company"},{"label":"Effective","value":"2026-02-19"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}